Please wait
S-3 S-3 EX-FILING FEES 0001734005 Niki BioSolutions, Inc. N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 Y N 0001734005 2026-08-28 2026-08-28 0001734005 1 2026-08-28 2026-08-28 0001734005 2 2026-08-28 2026-08-28 0001734005 3 2026-08-28 2026-08-28 0001734005 4 2026-08-28 2026-08-28 0001734005 5 2026-08-28 2026-08-28 0001734005 6 2026-08-28 2026-08-28 0001734005 7 2026-08-28 2026-08-28 0001734005 1 2026-08-28 2026-08-28 0001734005 2 2026-08-28 2026-08-28 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

Niki BioSolutions, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid Equity Class A Ordinary Shares, par value $0.00001per share 457(o) $ 0.00
Fees to be Paid Equity Preferred Stock 457(o) $ 0.00
Fees to be Paid Debt Debt Securities 457(o) $ 0.00
Fees to be Paid Equity Warrants 457(o) $ 0.00
Fees to be Paid Other Subscription Rights 457(o) $ 0.00
Fees to be Paid Other Units 457(o) $ 0.00
Fees to be Paid 1 Unallocated (Universal) Shelf 457(o) $ 75,000,000.00 0.0001381 $ 10,357.50
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 75,000,000.00

$ 10,357.50

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 8,265.00

Net Fee Due:

$ 2,092.50

Offering Note

1

Securities registered hereunder may be sold separately, together or as units with other securities registered hereunder. The registrant is registering an indeterminate number of securities for offer and sale from time to time at indeterminate prices, which shall have an aggregate offering price not to exceed $75,000,000. In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional number of securities that may be issued from time to time to prevent dilution as a result of a distribution, split, combination, or similar transaction. Securities registered hereunder may be sold separately, or together with other securities registered hereunder. Includes consideration to be received by the registrant, if applicable, for registered securities that are issuable upon exercise, conversion, or exchange of other registered securities. The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instructions to the Calculation of Filing Fee Tables and Related Disclosure (2)(A)(iii)(b) of Form F-3 under the Securities Act. Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act.

Table 2: Fee Offset Claims and Sources ☐Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims 1 F-3 333-292793 01/16/2026 $ 8,265.00
Fee Offset Sources Niki BioSolutions, Inc. F-3 333-292793 01/16/2026 $ 8,265.00
Rule 457(p)
Fee Offset Claims
Fee Offset Sources

Explanation of the basis for claimed offset:

1

Pursuant to Rule 415(a)(6) under the Securities Act, the registrant hereby carries forward unsold securities previously registered with a proposed maximum aggregate offering price of $75,000,000 (the "Offset Securities") under the registrant's prior registration statement on Form F-3 (Filer No. 333-292793) which was filed on January 16,2026 (the "Prior Registration Statement"). The Prior Registration Statement registered securities for a maximum aggregate offering price of $75,000,000, but did not sell any of the securities registered therein. In connection with the filing of the Prior Registration Statement, the registrant paid a filing fee of $8,265, calculated in accordance with Rule 457(o) under the Securities Act. The filing fees associated with the Offset Securities shall hereby offset the filing fees due with this current filing. . Pursuant to Rule 415(a)(6), the offering of the Offset Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.

Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date